COVID19 related status | COVID19 Nonrelated (Healthy) N = 74,687 | COVID19 Excluded (PCR-) N = 3577 | COVID19 Suspected (without PCR) N = 283 | COVID19 Confirmed (PCR+) N = 536 | P-value |
---|---|---|---|---|---|
Characteristic | n (%) | n (%) | n (%) | n (%) | |
Sociodemographical | |||||
Age group | |||||
50–64 yrs | 40,799 (54.6) | 1492 (41.7) | 216 (76.3) | 177 (33.0) | < 0.001 |
65–79 yrs | 24,638 (33.0) | 1186 (33.2) | 52 (18.4) | 137 (25.6) | |
≥ 80 yrs | 9250 (12.4) | 899 (25.1) | 15 (5.3) | 222 (41.4) | |
Sex | |||||
Men | 35,575 (47.6) | 1701 (47.6) | 115 (40.6) | 235 (43.8) | 0.036 |
Women | 39,112 (52.4) | 1876 (52.4) | 168 (59.4) | 301 (56.2) | |
Community-dwelling | 73,870 (98.9) | 3174 (88.7) | 280 (98.9) | 345 (64.4) | < 0.001 |
Nursing-home residence | 817 (1.1) | 403 (11.3) | 3 (1.1) | 191 (35.6) | |
Comorbidities | |||||
Neurological disease | 1935 (2.6) | 293 (8.2) | 10 (3.5) | 79 (14.7) | < 0.001 |
Renal disease | 3982 (5.3) | 420 (11.7) | 9 (3.2) | 65 (12.1) | < 0.001 |
Cancer | 5995 (8.0) | 549 (15.3) | 19 (6.7) | 67 (12.5) | < 0.001 |
Rheumatic disease | 804 (1.1) | 57 (1.6) | 4 (1.4) | 7 (1.3) | 0.032 |
Inflammatory bowel disease | 497 (0.7) | 27 (0.8) | 2 (0.7) | 6 (1.1) | 0.567 |
Respiratory disease | 6592 (8.8) | 567 (15.9) | 33 (11.7) | 80 (14.9) | < 0.001 |
Cardiac disease | 12,232 (16.4) | 1016 (28.4) | 34 (12.0) | 153 (28.5) | < 0.001 |
Atrial fibrillation | 3317 (4.4) | 392 (11.0) | 7 (2.5) | 70 (13.1) | < 0.001 |
Liver disease | 1338 (1.8) | 110 (3.1) | 6 (2.1) | 11 (2.1) | < 0.001 |
Diabetes | 12,322 (16.5) | 838 (23.4) | 31 (11.0) | 126 (23.5) | < 0.001 |
Hypertension | 32,604 (43.7) | 1937 (54.2) | 114 (40.3) | 290 (54.1) | < 0.001 |
Hypercholesterolemia | 25,638 (34.3) | 1398 (39.1) | 97 (34.3) | 181 (33.8) | < 0.001 |
Obesity | 20,468 (27.4) | 1013 (28.3) | 62 (21.9) | 135 (25.2) | 0.068 |
Smoking | 12,074 (16.2) | 591 (16.5) | 44 (15.5) | 41 (7.6) | < 0.001 |
Alcoholism | 1644 (2.2) | 134 (3.7) | 7 (2.5) | 11 (2.1) | < 0.001 |
Chronic medications use | |||||
Diuretics | 7586 (10.2) | 731 (20.4) | 25 (8.8) | 139 (25.9) | < 0.001 |
Beta blockers | 8817 (11.8) | 632 (17.7) | 35 (12.4) | 87 (16.2) | < 0.001 |
ACEIs | 15,374 (20.6) | 872 (24.4) | 59 (20.8) | 114 (21.3) | < 0.001 |
ARBs | 8317 (11.1) | 471 (13.2) | 27 (9.5) | 54 (10.1) | 0.001 |
Calcium channel blockers | 5990 (8.0) | 420 (11.7) | 16 (5.7) | 64 (11.9) | < 0.001 |
Statins | 15,063 (20.2) | 936 (26.2) | 44 (15.5) | 91 (17.0) | < 0.001 |
Oral anticoagulants | 3461 (4.6) | 385 (10.8) | 8 (2.8) | 58 (10.8) | < 0.001 |
Antiplatelet drugs | 8344 (11.2) | 676 (18.9) | 26 (9.2) | 108 (20.1) | < 0.001 |
Insulin | 2726 (3.6) | 271 (7.6) | 2 (0.7) | 43 (8.0) | < 0.001 |
Oral antidiabetic drugs | 9855 (13.2) | 623 (17.4) | 22 (7.8) | 85 (15.9) | < 0.001 |
Inhaled respiratory drugs | 5628 (7.5) | 552 (15.4) | 36 (12.7) | 77 (14.4) | < 0.001 |
Antineoplastic agents | 104 (0.1) | 12 (0.3) | 0 (0.0) | 0 (0.0) | 0.017 |
Systemic corticosteroids | 1105 (1.5) | 130 (3.6) | 7 (2.5) | 10 (1.9) | < 0.001 |
NSADs | 4079 (5.5) | 191 (5.3) | 30 (10.6) | 21 (3.9) | 0.001 |
Chloroquine | 154 (0.2) | 11 (0.3) | 2 (0.7) | 1 (0.2) | 0.176 |
Antihistamines | 3085 (4.1) | 152 (4.2) | 12 (4.2) | 15 (2.8) | 0.469 |
Proton-Pump Inhibitors | 16,254 (21.8) | 1423 (39.8) | 71 (25.1) | 183 (34.1) | < 0.001 |
Benzodiazepines | 12,026 (16.1) | 819 (22.9) | 75 (26.5) | 126 (23.5) | < 0.001 |
Vaccination’s history | |||||
Flu vaccine in prior autumn | 20,838 (27.9) | 1449 (40.5) | 61 (21.6) | 258 (48.1) | < 0.001 |
PPV23 | 24,189 (32.4) | 1666 (46.6) | 56 (19.8) | 272 (50.7) | < 0.001 |
PCV13 | 1005 (1.3) | 108 (3.0) | 8 (2.8) | 18 (3.4) | < 0.001 |
Tetanus | 47,761 (63.9) | 2507 (70.1) | 187 (66.1) | 344 (64.2) | < 0.001 |